508 filings
Page 12 of 26
8-K
8fkyde290 piv93dq4hk
3 Feb 15
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
xpuuh3sjfsioe2buh9e
26 Jan 15
Alnylam Pharmaceuticals Prices Public Offering of Common Stock
12:00am
424B5
zwef3hoy4c2b
21 Jan 15
Prospectus supplement for primary offering
12:00am
424B5
arkwizrh 93cei
20 Jan 15
Prospectus supplement for primary offering
12:00am
8-K
65t7e o1a
14 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
7hwim51b4oix
8 Jan 15
Results of Operations and Financial Condition
12:00am
8-K
9oi ix65l9o6tbqp
19 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
agasejkv0ctooap4
18 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
0cgc 3i37izqp5
5 Nov 14
Alnylam Pharmaceuticals Reports Third Quarter 2014 Financial Results and Highlights Recent Period Progress
12:00am
8-K
5ftaevz40slu4i
26 Sep 14
Submission of Matters to a Vote of Security Holders
12:00am
ARS
m9i19fgeyzz 1q
26 Aug 14
Annual report to shareholders
12:00am
8-K
3ne123vuboacrxk0u
7 Aug 14
Alnylam Pharmaceuticals Reports Second Quarter 2014 Financial Results and Highlights Recent Period Activities
12:00am
8-K
qoet9
2 Jul 14
Departure of Directors or Certain Officers
12:00am
CT ORDER
kxhca1ce7viiurle1
30 Jun 14
Confidential treatment order
12:00am
8-K
r0zcnuxfdf6vo9pdzqlv
8 May 14
Alnylam Pharmaceuticals Reports First Quarter 2014 Financial Results and Highlights Recent Period Activities
12:00am